Integrating network reconstruction with mechanistic modeling to predict cancer therapies

Melinda Halasz1,2, Boris N Kholodenko3,2,4, Walter Kolch1,2,4

  • 1Systems Biology Ireland, University College Dublin, Belfield, Dublin 4, Ireland. walter.kolch@ucd.ie tapesh.santra@ucd.ie melinda.halasz@ucd.ie.

Science Signaling
|November 24, 2016
PubMed

Insights

Computational analysis identified cancer-specific signal network rewiring. Targeting feedback inhibition of insulin receptor substrate 1 (IRS1) may restore sensitivity to epidermal growth factor receptor (EGFR) inhibitors in colorectal cancer.

Area of Science:

  • Oncology
  • Computational Biology
  • Systems Biology

Background:

  • Cancer cells exhibit altered signal transduction networks.
  • Identifying these network alterations is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To develop a computational framework for identifying, reconstructing, and modeling rewired signaling networks.
  • To predict potential therapeutic targets for cancer intervention using this framework.

Main Methods:

  • Developed a computational framework to analyze noisy perturbation response data.
  • Applied the framework to analyze epidermal growth factor receptor (EGFR) and insulin-like growth factor 1 receptor (IGF1R) pathways in colorectal cancer cells.
  • Experimentally validated computational predictions in cell lines and a zebrafish xenograft model.

Main Results:

  • The computational approach identified cell line-specific network rewiring in colorectal cancer.
  • Predicted that feedback inhibition of insulin receptor substrate 1 (IRS1) by p70S6K confers resistance to EGFR inhibition.
  • Experimental validation confirmed the predicted feedback loop's role in drug resistance.

Conclusions:

  • The developed computational framework can effectively model rewired signaling networks in cancer.
  • Disrupting the IRS1-p70S6K feedback loop is a potential strategy to overcome resistance to EGFR inhibitors in colorectal cancer.
  • This approach holds promise for personalized cancer treatment strategies.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K